If by "the future health of the company", you mean "ability to generate more profit down the line" then it's kinda tautological that (at a micro-level) those decisions are not going to lower the stock price - given that said stock price is derived from the net-present value of future returns.

That's of course assuming that the strategy is well-articulated and that the market understands it.